Testing effectiveness (Phase 2)Study completedNCT01030861
What this trial is testing
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Who this might be right for
Autoantibody PositiveNon-diabetic Relatives at Risk for Type 1 DiabetesHigh Risk+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 76